Skip to main content
Premium Trial:

Request an Annual Quote

Geneart to Provide Gene Variants for Max Planck Project

NEW YORK (GenomeWeb News) – Geneart today said that it has signed a contract to provide gene variants to the Max Planck Institute over the next two years for a systems biology research project.

Regensburg, Germany-based Geneart said that it will provide the genes and gene variants for the project "Mutanom — Systems Biology of Genetic Diseases," which is funded by Germany's Federal Ministry of Education and Research. The partners in the project include the Max Planck Institute for Molecular Genetics, the German Cancer Research Center, and the Max Delbrueck Center for Molecular Medicine, as well as clinical development partners.

Geneart said that order volume for the project is expected to be around €300,000 ($424,000).

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.